Category: CannabisNewsWire Release

CannabisNewsBreaks – Prime Harvest Inc. Featured in Latest Episode of Bell2Bell Podcast

Prime Harvest, a technology-focused, full-service cannabis company with horizontally diversified operations spanning various segments of the cannabis value chain, was featured in the Bell2Bell Podcast, a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Duane Alexander, CEO of Prime Harvest, joined the latest episode to discuss to discuss the company, its flagship brand and seasoned management team, recent milestones, and goals for the balance of 2022 and beyond. “Prime Harvest is a vertically integrated cannabis company. We’re based out of San Diego … and we’re positioned to expand into other markets in the State of California. We work in the licensing aspect [of the cannabis industry] and compliance. We also work in distribution, as well as branding and marketing,” Alexander said. “Jaxx is our flagship retail brand. We’ve currently positioned it in Ramona, San Diego County. We have another location that was recently licensed in the City of La Mesa, and we have three other locations in the pipeline for expansion this year.”

To view the full press release, visit https://cnw.fm/DWFvx

About Prime Harvest Inc.

Prime Harvest is a technology-focused, full-service cannabis corporation. The company is horizontally diversified across various segments of the cannabis value chain, including licensing acquisition and compliance management, and state-wide direct-to-consumer operations. Based in the innovation hotspot of San Diego, California, Prime Harvest is expanding its footprint throughout the Golden State by executing a long-term strategy of investing in the growth and scale of licensed assets anchored by the power of data-driven technology. Prime Harvest’s flagship retail brand, Jaxx Cannabis, upholds exceptional standards of quality and services and provides a rewarding experience for customers in San Diego and the surrounding Southern California communities. Trust and credibility are at the heart of everything that the team at Prime Harvest stands for. The Prime Harvest team is composed of true experts in their respective fields, carefully assembled with the aim of building a world-class organization that can drive the cannabis industry and movement forward. For more information about the company, visit www.PrimeHarvestInc.com.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest are available in the company’s newsroom at https://cnw.fm/PRIME

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

New Agreements Signed Between Lexaria Bioscience Corp. (NASDAQ: LEXX) and BevNology LLC; Pre-IND Meeting Request Filed with FDA

  • The two companies signed a manufacturing operating agreement and a commercial agreement 
  • Lexaria sent a pre-IND meeting request letter to the US FDA and plans to file the full IND application in late 2022/early 2023
  • The FDA has acknowledged Lexaria’s pre-IND request and responded with conditions prior to the target date of July 30, 2022

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has recently announced signing two agreements with BevNology LLC, the product and development arm of InterContinental Beverage Capital (“IBC”), operating its state-of-the-art lab and manufacturing facility just outside of Atlanta, Georgia. This announcement only furthers Lexaria’s leverage of the market, with the company’s patented DehydraTECH(TM) technology having already been embraced by several consumer packaged goods brands, with availability in over 7,000 stores throughout the United States and Japan, including direct-to-consumer online retail portals (https://cnw.fm/Bjc3R).

The manufacturing operating agreement expands the production capabilities of Lexaria’s growing list of business-to-business clientele interested in purchasing DehydraTECH-powered active ingredients for packaged-goods brands. The new, state-of-the-art processing facility built by BevNology is operational, increasing and broadening production capabilities. This facility is currently serving Lexaria’s corporate clientele, with new equipment specific to DehydraTECH already installed.

The second agreement is a commercial license, empowering BevNology to offer the DehydraTECH products with active ingredients derived from hemp, including cannabidiol (“CBD”), under BevNology and partnered brands. The agreement is non-exclusive for powdered DehydraTECH formulations. For liquid formulations, the non-exclusivity is limited in the United States only, requiring certain minimum fee payments to maintain rights. Lexaria will receive royalties from BevNology for the utilization under this license, with exclusion only affecting Japan, the Republic of Korea, and the People’s Republic of China.

“These agreements build on a long-standing and very successful product development consulting relationship between Lexaria and the expert scientists and personnel at BevNology.” Lexaria CEO Chris Bunka said. “BevNology’s formulation and production capabilities are class leading, and we are confident that our new relationship with our trusted partner will propel new and exciting growth opportunities for both companies.”

In other recent news, Lexaria has filed its pre-IND meeting request letter with the United States Food and Drug Administration (“FDA”) to initiate communication with the FDA regarding Lexaria’s development of the company’s DehydraTECH-CBD for potential hypertension treatment. The FDA has responded to and confirmed the company’s letter, with a target date of July 30, 2022, and disclosed the conditions in which Lexaria must meet prior to the meeting. Lexaria anticipates filing the full IND application in late 2022/early 2023 (https://cnw.fm/Hcn8w).

“We are excited to take this important first regulatory step with the FDA for the development of our DehydraTECH-CBD for the treatment of hypertension,” stated John Docherty, President of Lexaria. “Submission of this request letter initiates formal communication with the FDA regarding our IND clinical trial plans in order to help define the critical path for clinical development and marketing approval of our potentially very significant new hypertension therapeutic.”

The hypertension treatment market is valued at approximately $28 billion per year and is expected to grow as one of the world’s top health problems as a subset of a larger heart disease market (https://cnw.fm/hFsR2). There are over 1.1 billion people in the world suffering from hypertension, with fewer than 1 in 4 having successful control over it. The potential market size increases if an affordable drug were available with few or no side effects. Some reports indicate drugs for hypertension and related conditions are among the highest-selling category of drugs in the world (https://cnw.fm/RK0IU). 

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Congressmen Plead for Support for Medical Cannabis Bill for Veterans

A duo of bipartisan congressmen is seeking support for an upcoming bill that would increase military veterans’ access to medical cannabis. Although studies have found that medical cannabis can be effective at helping veterans deal with chronic pain, insomnia, anxiety, depression and even post-traumatic stress disorder (PTSD), federal policy makes it extremely difficult for veterans to access legal cannabis.

Democratic Rep. Earl Blumenauer and Republican Rep. Brian Mast are hoping to change this through their Veterans Equal Access Act. The bill would grant healthcare practitioners at the U.S. Department of Veterans’ Affairs (VA) permission to recommend medical cannabis to patients in states with legal cannabis markets.

The two congressmen, cochairs of the Congressional Cannabis Caucus, also shared a letter to other House offices asking those officials to support their bill because it would ensure that veterans had equal access to state-legal medical cannabis. The letter stated that while most state-legal medical cannabis programs will allow patients with a recommendation from a medical provider to enroll, VA policy bars Veteran Affairs doctors and care providers from taking part in medical cannabis programs, including helping veterans fill requisite forms.

This policy makes it virtually impossible for military veterans who could benefit a great deal from medical cannabis treatment to enroll in state-legal medical cannabis programs without having to seek medical care outside of the Veteran Affairs system, the letter stated. The policy often results in gaps in care, interrupts the continuity of care and forces veterans to pay for medical cannabis out of pocket.

The letter notes that VA clinicians shouldn’t be prohibited from recommending medical marijuana treatment to their patients if the veteran’s condition warrants it. Furthermore, it states that veterans shouldn’t be forced to leave the VA system just to access a medical treatment that is legal in their state.

The Veteran Access Act would give VA providers authorization to provide recommendations, offer their opinions on medical cannabis and help veterans complete forms pertaining to medical cannabis.

However, the letter noted that the upcoming legislation didn’t allow VA clinicians to dispense or prescribe patients with medical marijuana nor did it mean that they are required to provide recommendations and help with paperwork relating to medical marijuana programs. All the legislation does is allow VA clinicians to talk about medical cannabis candidly with their patients and offer recommendations and opinions that are in their best interests.

The letter also states that the legislation already has the support of several veteran and cannabis advocacy groups including NORML, Veterans Cannabis Coalition, Council for Federal Cannabis Regulation, Drug Policy Alliance, U.S. Cannabis Council, and Iraq and Afghanistan Veterans of America (IVAV).

It is unfortunate that veterans seem to be getting the short end of the stick when it comes to accessing medical marijuana while they deserve the best after serving their nation with utmost dedication. Modifying the discriminatory regulations would allow those who live in states where home grows are allowed to also grow their own cannabis, perhaps even using micro gardens such as those sold by Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Do Cryptos, Blockchain Have Potential for Use in the Marijuana Industry?

You wouldn’t think marijuana has any connection to cryptocurrency and the complex blockchain technology that authenticates and records transactions. The former is a psychoactive plant that has been associated with racial injustices for decades and is now touted for its medical potential while the latter is an online decentralized currency that has taken the world by storm in recent years.

However, a deeper look reveals ways in which the two emerging industries are compatible. Since federal law still considers cannabis to be a Schedule I drug, cannabis industry actors have a hard time accessing basic financial services. Most times, they are forced to operate on a cash-only basis, which puts them at risk of robberies and makes financial tracking and tax compliance difficult.

Cryptocurrencies such as Bitcoin and Ethereum could allow the industry to access much-needed financial and accounting services. According to Mark Lozzi, founder and CEO of a marijuana financial services company called Conifa, a stable coin that’s capable of weathering the industry’s volatility would best serve the cannabis industry.

Such a stable coin would be used for consumer payments and business-to-business transactions. Consumer payments would be a relatively easy way to introduce this stable coin into the state-legal cannabis industry, says Lozzi. Allowing customers to purchase cannabis using cryptocurrency would increase their purchasing power while ensuring the industry is on par with modern-day innovations and interests.

On the other end of the spectrum, cryptocurrency and blockchain technology could be used to build a completely “immutable and auditable” banking infrastructure for cannabis growers, processors and retailers, Lozzi says. Blockchain would also make it possible to build a financial system capable of tracking cash and products. The cannabis industry is desperately in need of a centralized framework for oversight and compliance, and blockchain technology has the potential to fill this gap.

Lozzi acknowledges that the SAFE Banking Act, which will prohibit federal regulators from penalizing financial institutions that provide banking services to state-legal cannabis businesses and ancillary businesses, may soon become law and increase the industry’s access to financial services. Still, cryptocurrency payments could coexist alongside regular currency due to their speed and flexibility.

Furthermore, blockchain technology can still support oversight and compliance in the industry as it provides auditability and immutability, Lozzi says. He notes that blockchain solutions should be used within a strong and compliant infrastructure to ensure that they track the flow of money in compliance with industry requirements and guidelines.

With the cryptocurrency market currently seeing a major decline in value, Lizzo believes the winner will emerge as a stable coin.

The cannabis industry and its leading players such as American Cannabis Partners would appreciate all available payment options given the challenging regulatory environment in which they operate, so alternatives such as using cryptos wouldn’t be such a bad idea for the industry.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Zacks Report Highlights Flora Growth Corp. (NASDAQ: FLGC) Aspiring to Benefit from First Mover Advantage in Multiple Cannabis Market Categories

  • Flora’s 2021 acquisitions allowed it to expand its operations beyond North America and into Europe
  • Acquisitions have also contributed to 450% YOY revenue growth for Q1 2022
  • Its management is confident that the foundation laid down so far will yield growth for 2022 and subsequent financial years
  • Flora has also reiterated 2022 revenue guidance of $35 million to $45 million

2021 was an excellent year for Flora Growth (NASDAQ: FLGC). According to a recent research report from Zacks (https://cnw.fm/bWU0H), the company possesses a number of important qualities pointing to continued significant growth following a strong 2021. Flora Growth management even regarded the past year as “transformational,” particularly following the closing of supplier, vendor, and distribution agreements that would see the company expand its operations, market reach, and product line.

With the progress made by the company so far, it is looking to benefit from a first-mover advantage in multiple market categories in terms of increased value for its shareholders, a higher market share, and increased revenue going forward.

The report went on to talk about 2021’s acquisition of Vessel Brand, Inc., a move that allowed the company to establish a foothold in the United States cannabis accessories business while improving its e-commerce capabilities. The year would also see the construction of an all-outdoor cultivation and on-site extraction facility in Colombia, one of the largest traditional flower exporters in the world and now able to export cannabis flowers.

Such moves position Flora to take advantage of the potential of the marijuana industry, particularly the medical marijuana sector. According to a report from Grand View Research, the global medical marijuana market size was valued at USD 11.0 billion in 2021 and is projected to expand at a compound annual growth rate (“CAGR”) of 21.6% from 2022 to 2030 (https://cnw.fm/26BIe).

Through its acquisitions, Flora has expanded its operations beyond North America and into Europe. The company’s investment in Hoshi International, for instance, opened it to the European Union (“EU”), allowing it to expand its global footprint that would further spread to Hong Kong, Latin America, and Israel.

The report also pointed out Flora’s Life Sciences pillar, one of its three key pillars of growth, focused on providing scientific-based research associated with cannabis. The other two pillars include Commercial and Wholesale and House of Brands. The company believes that, while offering the products in its portfolio is critical, educating consumers and potential customers is of the essence if the conversation around cannabis is to be advanced. Therefore, Flora remains committed to creating educational platforms and conducting research studies and clinical trials to develop plant-based, medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements.

Through its acquisitions and growing distribution network, Flora was able to post a 450% year-over-year revenue growth for the first quarter of the 2022 financial year. As a result, its management is confident that, for the entire fiscal year, the company will post between $35 million and $45 million in revenue. 

This will be significantly influenced by the JustCBD acquisition, the awarding of an export quota for 43.6 tons of high-THC cannabis in Colombia, and the successful completion of the requisite steps to allow for the commercial planting and export of psychoactive cannabis.

Flora looks to reach cash flow breakeven as revenue continues to ramp, having closed the 2021 fiscal year with about $37.6 million in cash and a $21.4 million loss. 2021 was its first full year of revenue. Still, the company anticipates accelerating revenue growth in 2022 as it activates its Wholesale and Life Sciences growth units while simultaneously fueling expansion in the global House of Brands.

Flora is aggressively pushing its brand and advancing the conversation around cannabis. In addition, with its able management, Flora is recognizing and capitalizing on opportunities that others are yet to identify, placing it in a unique position that not only gives it a first-mover advantage, but also presents a unique opportunity for growth.

The full Zacks Small-Cap Research Report is available at https://cnw.fm/bWU0H.

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Can Enable ‘New Breed of Farmers’

Advanced Container Technologies (OTC: ACTX) today announced that GrowPods — transportable modular hydroponic farms — can help democratize food production around the world. Technology has made farming easier since the arrival of the plow thousands of years ago. Farmers now have access to advanced robots, automated facilities, self-driving tractors, and pollinator drones. With technology, community groups, entrepreneurs, schools, and all types of organizations are enabled to grow their own fruits and vegetables, as automated systems like GrowPods have made it simple for anyone to become a farmer. “GrowPods can be placed virtually anywhere and can grow the equivalent of three acres of traditional farmland in an automated environment that can be controlled and monitored remotely. Some units have been configured to grow up to 720 heads of lettuce each week, without pesticides, harmful chemicals, or risk of contamination,” the announcement reads. “With GrowPods, a new breed of ‘farmers’ can grow fresh, healthy food, without needing hundreds of acres of farmland or dozens of workers to tend the fields.”

To view the full press release, visit https://cnw.fm/qc0zL

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Research Finds Weekly Use of Marijuana Doesn’t Compromise Physical Health

With dozens of states passing some form of cannabis legislation in the past decade, more people than ever are using marijuana for either medical or recreational purposes. According to recent research, regular cannabis use has a minimal effect on a user’s physical health. The study adds to the growing body of research on how marijuana affects pulmonary, cardiovascular and other biological functions.

Since federal law has made it virtually impossible for researchers to study cannabis for the past few decades, most of the research on the effects of regular cannabis use is quite new.

This recent study, whose findings were reported in the Drug and Alcohol Dependence journal, sought to investigate the effect of regular (once a week) cannabis use on physical health. The results indicated that the plant didn’t have detrimental effects.

The research involved data from roughly 300 pairs of twins which was sourced from the University of Colorado Boulder’s “Colorado Adoption/Twin Study of Lifespan Behavioural Development and Cognitive Aging” study. This is an ongoing study of cognitive aging in twins from infancy to adulthood to determine how different influences in childhood and adulthood affect cognitive functioning. The researchers specifically tracked factors that influence declines, maintenance or boosts in cognitive abilities.

Jessica Megan Ross, the study’s lead researcher, and her team looked at how these factors affected dizygotic twins, who share 50% of their genes, and monozygotic twins, who share 100% of their genes. They also drew data from a larger study that has been assessing twins and siblings on a yearly basis from birth into early adulthood.

After analyzing the data, the researchers  found that the increased use of marijuana during adolescence wasn’t necessarily associated with reduced physical activity or exercise in adulthood. Furthermore, they found that increased use of cannabis as an adult isn’t necessarily associated with regular appetite loss either.

Comparing data between siblings showed that the frequent use of cannabis as a teen was associated with less exercise in adulthood.

However, the comparison of the pairs of monozygotic twins revealed that regular cannabis use in adulthood was associated with a lower resting heart rate, suggesting shared family factors could be responsible for the association between adolescent cannabis use and infrequent exercise in adulthood.

The researchers concluded that there was a minimal connection between using cannabis once a week and negative physical health outcomes for adults aged 25 to 35. They also noted that this didn’t apply to adolescents and adults who used cannabis more than once a week.

Ross added that while their research did not reveal a connection between regular cannabis use (once a week) and poor physical health, regular use could have side effects, including the development of a cannabis use disorder.

There is growing evidence that marijuana isn’t as bad as prohibitionists say it is, and such research findings may indirectly boost the sales of entities such as Advanced Container Technologies Inc. (OTC: ACTX), which makes equipment that can be used to grow cannabis and other plants.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Events Could Revive Atlantic City’s Glory

For decades, Atlantic City was a popular tourist destination for folks of all ages looking to enjoy the city’s diverse set of entertainment spots. Starting out as a resort town more than one hundred years ago, Atlantic City saw its fortunes change when Resorts International opened its casino doors in 1978.

The city peaked in 2006 with a revenue of some $5.2 billion behind Las Vegas’ revenue of $10.6 billion. However, Atlantic City’s fortunes have been on a decline ever since. The Taj Mahal Casino, owned by former president Donald Trump, shut its doors in 2016, and the Revel Casino Hotel was sold in 2018.

Now that dozens of states have legalized cannabis, Atlantic City may be able to regain some of its former glory by taking advantage of the tremendous demand for cannabis. Marijuana has proven to be an extremely lucrative product, generating billions of dollars in taxes and providing hundreds of thousands of employment opportunities.

For starters, dispensaries in New Jersey had sold $24 million worth of recreational cannabis just one month after legal adult-use cannabis sales launched, representing the industry’s immense potential.

A recent Skift Meetings report found that cannabis has the potential to alleviate the city’s financial woes and help its economy recover. Since Atlantic City has more than 15,000 hotel rooms, it is a perfect place to hold large cannabis conventions. Cannabis trade shows such as CHAMPS trade shows or MJBizCon can bring in tens of thousands of tourists and generate significant revenue for the city.

Speaking at the Skift Meetings, Bridge Strategic Communications president Stu Zakim said that the city could be a wildly successful destination for cannabis conventions that require large facilities. Larry Seige, president and CEO of AC, was in agreement, stating that cannabis legalization laws have opened up a new market for meetings and conventions in the city that will have a significant economic impact.

According to the 3rd annual New Jersey Cannabis Convention (NECANN), which will be held at the Atlantic City Convention Center from Sept. 9–10, 2022, Atlantic City’s cannabis market is huge, untapped and brimming with potential. The state of New Jersey legalized recreational cannabis in February, and the industry, which is already generating millions of dollars in sales, has significant potential for growth.

Projections from MJBizdaily show that New Jersey’s recreational cannabis market is projected to achieve a valuation of $2 billion in 2026 from $625 to $775 million in 2021.

These high sales figures show just how huge the potential market for cannabis products from companies such as American Cannabis Partners can be once there are reforms at the federal level and prohibition is ended.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Advanced Container Technologies Inc. (ACTX) GrowPods Strengthen Company’s Position in Growing Multibillion-Dollar Market

  • The global indoor farming market projected to grow from $26.5 billion in 2021 to $62 billion by 2030
  • Report indicates that United States holds major share in terms of revenue in North America indoor farming market
  • Grow Pods offered through ACTX provide a controlled environment, ability to grow year-round

The newest projections for the global indoor farming sector are in, and the numbers bode well for Advanced Container Technologies (OTC: ACTX). ACTX is the exclusive U.S. distributor of Grow Pods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops all year long. 

“The study undertaken by Astute Analytica foresees a tremendous growth in revenue of the market for the global indoor farming market from US$26.5 billion in 2021 to US$62 billion by 2030,” a recent PR Newswire report states (https://cnw.fm/sIUv2). “The market is anticipated to grow at a CAGR of 10.1% during the forecast period 2022–2030.

The article notes that indoor vertical farming is defined as the practice of growing produce stacked one above another in a closed, controlled environment. “Growing crops on vertically mounted shelves significantly reduces the amount of land space needed to grow plants compared to traditional farming methods,” the article observes. 

“Vertical farms are unique in the sense that some setups do not require soil for plants to grow,” the article continues. “Most are either hydroponic, where vegetables are grown in a nutrient-dense bowl of water, or aeroponic, where the plant roots are systematically sprayed with water and nutrients. Moreover, vertical farms use smart sensors to monitor technical variables including temperature, carbon dioxide, oxygen, lighting, humidity, nutrient concentration, pH, pest control, irrigation and harvesting.”

The Astute Analytica report showed that the United States holds the major share in terms of revenue in the North America indoor farming market, with projections to grow with the highest CAGR during the forecast period. “Moreover, developed countries such as U.S. and Canada are the rapid and early adopters of indoor farming technologies,” the article said. “Furthermore, based on the growing system, the hydroponics segment holds the highest share in the North America indoor farming market in 2021 as it reduces the amount of space and water required for cultivation.”

Offering the ability to grow high-quality crops anywhere, the Grow Pods offered through Advanced Container Technologies provide a controlled environment and the ability to grow year-round. The micro-farms also enable cultivation in a smaller footprint using less resources — huge advantages in a world where environmental and sustainability concerns are top priorities for consumers.

In November 2020, ACTX announced that it had entered into an agreement with Grow Pods manufacturer GP Solutions for the exclusive right to market, sell and distribute GP products in the United States and its territories (https://cnw.fm/MZKeB). At the time of the agreement, GP Solutions president George Natzic stated that “we are very enthusiastic about this agreement and look forward to letting the experts at ACT handle sales and marketing while we focus on manufacturing new products, and expanding into new industries and territories.”

For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Reach of its Drug Delivery Technology Through Newly Inked Agreements with Beverage Developer BevNology

  • Drug delivery technology innovator Lexaria Bioscience has developed a patented technology showing superiority in animal and human testing as a means of improving existing drug brands’ performance and establishing new solutions for unmet medical needs
  • The company recently announced agreements with beverage developer BevNology to expand production capabilities for Lexaria’s own growing list of B2B clientele and empowering BevNology to offer DehydraTECH products with active ingredients derived from hemp including CBD under BevNology and partnered brands 
  • The technology is called DehydraTECH — improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery  
  • Lexaria also recently announced an agreement with Ireland’s Anodgen Bioceuticals that allows Anodgen to manufacture and distribute DehydraTECH processed cannabinoid API powders within Europe including the UK, Australia and New Zealand

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has built the reputation of its patented DehydraTECH drug delivery technology through a growing data set of potential medicinal applications and through an expanding list of licensing agreements with third-party companies interested in its potential for cannabidiol (“CBD”)-based products. 

Lexaria’s patented DehydraTECH technology transforms a wide variety of orally and topically administered products into enhanced solutions that make the APIs more rapidly available and effective at lower doses while adding zero chemical byproducts. 

Among the licensing partnerships announced by the company are recent agreements with beverage developer BevNology and Ireland API manufacturer and distributor Anodgen Bioceuticals. 

The BevNology collaboration was announced June 21 and not only includes a commercial license agreement for products with active ingredients derived from hemp under BevNology’s brand, but also a manufacturing operating agreement utilizing BevNology’s new, custom-built state-of-the-art processing facility outside Atlanta.

“These agreements build on a long standing and very successful product development consulting relationship between Lexaria and the expert scientists and personnel at BevNology,” Lexaria CEO Chris Bunka stated in announcing the BevNology development (https://cnw.fm/6it3Q). “BevNology’s formulation and production capabilities are class leading and we are confident that our new relationship with our trusted partner will propel new and exciting growth opportunities for both companies.”

The manufacturing agreement will help Lexaria broaden its production capabilities for its own growing list of B2B clientele interested in purchasing DehydraTECH-powered active ingredients for consumer packaged-goods brands.  Lexaria has already installed all required commercial DehydraTECH manufacturing equipment at the facility. 

The licensing agreement addresses powdered DehydraTECH formulations and liquid formulations that tend toward BevNology’s particular expertise. Both elements of the agreement are non-exclusive, except that the liquid formulations have limited exclusivity in the United States and complete exclusion in Japan, the Republic of Korea, and the People’s Republic of China. 

The Anodgen licensing agreement was announced earlier in the month and includes a five-year non-exclusive DehydraTECH license for powdered CBD-based products in Europe including the United Kingdom, Australia, and New Zealand. 

Under the license, Anodgen can use DehydraTECH not only for making and selling medical application CBD products but also pharmaceutical applications for psychoactive cannabinoids (https://cnw.fm/JjYBn). Anodgen is building a new facility in Ireland and expects to be fully operational later this year, creating the potential for long-term use of DehydraTECH for the pharmaceutical market. 

Independent third-party testing has evidenced DehydraTECH’s ability to enhance the performance of a variety of pharmaceutical and wellness industry products and has led to a pre-Investigational New Drug (“IND”) meeting with the U.S. Food and Drug Administration (“FDA”) to file DehydraTECH-CBD as a prospective registered treatment for hypertension this year (https://cnw.fm/M6RAk). 

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.